Catheter ablation was associated with significantly fewer deaths and hospitalizations for worsening heart failure than medical therapy in a randomized trial of patients with atrial fibrillation (AFib) and heart failure.

A pair of researchers at Utah State University are aiming to revolutionize the world of digital monitoring with a new technology that can measure a person’s heartbeat using nothing more than a video camera and specialized software, the university announced Monday.

Four in ten cardiomyopathies are familial, suggesting an urgent need for more widespread genetic testing, a team of cardiologists reported in the European Heart Journal this week.

In his 17 years as a dentist, Robert Camenzuli has seen allergic reactions, chest pains and seizures cycle through his office. But this January came with a first—a 53-year-old patient who went into cardiac arrest.

Atrial fibrillation (AFib) patients face higher odds for short-term cancer diagnoses but, depending on how long they've had AFib, the could face lower odds for cancer in the long run, a January study states.

Nearly half of all out-of-hospital cardiac arrest (OHCA) survivors struggle to rejoin the workforce and participate in society post-heart attack, a study published in Circulation: Cardiovascular Quality and Outcomes suggests.

TITUSVILLE, N.J., Jan. 16, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced findings from the U.S. Food and Drug Administration's (FDA) Mini-Sentinel assessment, confirming the positive safety and efficacy profile of XARELTO® (rivaroxaban) established in the phase III ROCKET AF clinical trials, were published in Pharmacoepidemiology & Drug Safety.

Asymptomatic atrial fibrillation (AFib) patients could be at a heightened risk for cardiac complications, especially if the condition is paroxysmal, a study published in CHEST reports.